Subscribe

Rocket Doctor AI Inc. (AIDR.CN)

CAD0.57 +0.01 (+1.79%)
CA CNQ Healthcare Medical - Healthcare Information Services
Address 800 – 885 West Georgia Street V6C 3H1
Vancouver, BC, CA
CEO Essam Hamza
Website treatment.com
IPO 2021-04-19
ISIN CA7729241066

Explore sections of this company profile

Also trades on Canadian Securities Exchange · AIDR.CN (CAD) Canadian Securities Exchange · TRUE.CN (CAD) Other OTC · AIRDF (USD) Other OTC · TREIF (USD)
Description

Rocket Doctor AI Inc., based in Vancouver, Canada, specializes in delivering personalized healthcare information services across the Canadian market. The company develops a mobile application crafted to help users assess their symptoms and effectively manage their health issues, concerns, and ongoing wellness journey. This sophisticated digital health platform also functions as an insightful assessment tool, offering valuable health analytics. Furthermore, Rocket Doctor AI Inc. provides a range of additional solutions, including medical education resources, tools for medical clinics, expert clinical advisory services, and a comprehensive healthcare information hub. Established in 2018, the company was formerly known as Treatment.com AI Inc. and is slated to officially adopt the name Rocket Doctor AI Inc. in August 2025.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
CAD0.57 +0.01 (+1.79%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
187.2K
Beta
-0.39
Float Shares
36.53M
Free Float %
43.0%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-3.28% -4.84% -4.84% -18.06% -35.87% -19.18% +57.33% -9.23% -99.04% -98.13% -98.13%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
0.57
DCF (Unlevered) 0.04 -93.3%
DCF (Levered) 0.03 -94.4%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 100% Bullish
Rating 2026-05 Change
Strong Buy 0 0
Buy 1 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
-2.06
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
2 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
  • ✓
    Revenue growth Medical - Healthcare Information Services: +14.2%
    +15,725.5% ★
  • ✗
    EPS growth Medical - Healthcare Information Services: +43.1%
    -15.8% Q1'26: -25.0% (vs Q1'25)
  • ✗
    FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%
    -646.0% Q1'26: -420.4% (vs Q1'25)
  • ✗
    EBIT margin Medical - Healthcare Information Services: +8.8%
    -767.2% Q1'26: -626.7% (vs Q1'25)
  • ✗
    ROIC Medical - Healthcare Information Services: +5.2%
    -406.0% Q1'26: -569.9% (vs Q1'25)
  • ✗
    Share dilution Medical - Healthcare Information Services: -0.1%
    +81.5% Q1'26: +65.8% (vs Q1'25)
  • ✗
    Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×
    -0.04× Q1'26: -0.03× (vs Q1'25)
Valuation Multiples From To
DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (-0.40) × ERP
WACC = 99% × Ke + 1% × Kd (23.2%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 0.04 Current price: 0.57
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2025
actual 		Dec 2026
1 Rev. Ana.
1 EPS Ana. 		Dec 2027
1 Rev. Ana.
1 EPS Ana. 		Dec 2028
1 Rev. Ana. 		Dec 2029
1 Rev. Ana. 		Dec 2030
1 Rev. Ana.
Revenue
1.74M
est: 1.61M (+7.7%)
4.16M
4.16M – 4.16M
+157.6% YoY
6.07M
6.07M – 6.07M
+45.9% YoY
14.67M
14.67M – 14.67M
+141.7% YoY
22.30M
22.30M – 22.30M
+52.0% YoY
29.92M
29.92M – 29.92M
+34.2% YoY
EBITDA
-11.76M
est: 968.6K (-1,314.3%)
2.50M
2.50M – 2.50M
+157.6% YoY
3.64M
3.64M – 3.64M
+45.9% YoY
8.80M
8.80M – 8.80M
+141.7% YoY
13.38M
13.38M – 13.38M
+52.0% YoY
17.95M
17.95M – 17.95M
+34.2% YoY
EBIT
-13.34M
est: 968.6K (-1,477.6%)
2.50M
2.50M – 2.50M
+157.6% YoY
3.64M
3.64M – 3.64M
+45.9% YoY
8.80M
8.80M – 8.80M
+141.7% YoY
13.38M
13.38M – 13.38M
+52.0% YoY
17.95M
17.95M – 17.95M
+34.2% YoY
Net Income
-15.69M
est: -5.18M (-203.0%)
-5.18M
-5.18M – -5.18M
+0.0% YoY
-3.98M
-3.98M – -3.98M
+23.1% YoY
—
— – —
+100.0% YoY
—
— – —
—
— – —
SGA
13.08M
est: 164.42M (-92.0%)
423.55M
423.55M – 423.55M
+157.6% YoY
618.17M
618.17M – 618.17M
+45.9% YoY
1.49B
1.49B – 1.49B
+141.7% YoY
2.27B
2.27B – 2.27B
+52.0% YoY
3.05B
3.05B – 3.05B
+34.2% YoY
EPS
-0.22
est: -0.13 (-69.2%)
-0.13
-0.13 – -0.13
+0.0% YoY
-0.10
-0.10 – -0.10
+23.1% YoY
—
— – —
+100.0% YoY
—
— – —
—
— – —
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-11 C 2/5 2/5 1/5 1/5 3/5 1/5 2/5
2026-05-08 C 2/5 2/5 1/5 1/5 3/5 1/5 2/5
2026-05-07 C 2/5 2/5 1/5 1/5 3/5 1/5 2/5
2026-05-06 C 2/5 2/5 1/5 1/5 3/5 1/5 2/5
2026-05-05 C 2/5 2/5 1/5 1/5 3/5 1/5 2/5
2026-05-04 C 2/5 2/5 1/5 1/5 3/5 1/5 2/5
2026-05-01 C- 1/5 2/5 1/5 1/5 2/5 1/5 2/5
2026-04-30 C- 1/5 2/5 1/5 1/5 2/5 1/5 2/5
2026-04-29 C- 1/5 2/5 1/5 1/5 2/5 1/5 2/5
2026-04-28 C- 1/5 2/5 1/5 1/5 2/5 1/5 2/5
2026-04-27 C- 1/5 2/5 1/5 1/5 2/5 1/5 2/5
2026-04-24 C 2/5 3/5 1/5 1/5 2/5 1/5 2/5
2026-04-23 C 2/5 3/5 1/5 1/5 2/5 1/5 2/5
2026-04-22 C 2/5 3/5 1/5 1/5 2/5 1/5 2/5
2026-04-21 C 2/5 3/5 1/5 1/5 2/5 1/5 2/5
2026-04-20 C 2/5 3/5 1/5 1/5 2/5 1/5 2/5
2026-04-17 C 2/5 3/5 1/5 1/5 2/5 1/5 2/5
2026-04-16 C 2/5 3/5 1/5 1/5 2/5 1/5 2/5
Ownership data is not available for this company yet.

Executive team

Top executives
EBIT / Employee
-44.5K
Shares Outstanding
84.97M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Christopher Cherry Interim CFO & Director — male
Essam Hamza Chief Executive Officer & Director — —
Kelly Pladson Corporate Secretary — female
Richard Atkins Chief Operating Officer — male
Robert Scott Chief Innovation Officer — —
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Medical - Healthcare Information Services